Literature DB >> 16619159

HIV infection and dementia in older adults.

Victor Valcour1, Robert Paul.   

Abstract

Human immunodeficiency virus (HIV) infection in older patients is becoming increasingly common as seropositive individuals live longer because of long-term antiretroviral treatment. Simultaneously, the development and expression of dementia among HIV-infected patients is evolving in the era of highly active antiretroviral therapy (HAART) and immune reconstitution. How long-term HAART interacts with chronic HIV infection and advanced age with regard to cognition is not fully understood. This article provides an overview of HIV cognitive impairment as it relates to aging and presents some emerging issues in the field. Particular emphasis is placed on describing the changing landscape of HIV-related cognitive impairment and discussing possible concerns regarding the long-term effects of antiretroviral treatment. A brief discussion of potential adjunctive therapies to reduce cognitive symptoms associated with HIV infection in older individuals is provided.

Entities:  

Mesh:

Year:  2006        PMID: 16619159     DOI: 10.1086/503565

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.

Authors:  Ari S Nowacek; JoEllyn McMillan; Reagan Miller; Alec Anderson; Barrett Rabinow; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-17       Impact factor: 4.147

2.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 3.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

4.  HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Authors:  Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

Review 5.  Recent trends on hydrogel based drug delivery systems for infectious diseases.

Authors:  Arti Vashist; Ajeet Kaushik; Atul Vashist; Rahul Dev Jayant; Asahi Tomitaka; Sharif Ahmad; Y K Gupta; Madhavan Nair
Journal:  Biomater Sci       Date:  2016-10-18       Impact factor: 6.843

6.  Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults.

Authors:  Erin E Morgan; Steven Paul Woods; Lisa Delano-Wood; Mark W Bondi; Igor Grant
Journal:  Neuropsychology       Date:  2011-09       Impact factor: 3.295

Review 7.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

8.  HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice.

Authors:  Brian Giunta; Houyan Hou; Yuyan Zhu; Elona Rrapo; Jun Tian; Mori Takashi; Deborah Commins; Elyse Singer; Johnny He; Francisco Fernandez; Jun Tan
Journal:  Int J Clin Exp Pathol       Date:  2009-01-30

9.  Patterns and correlates of sexual activity and condom use behavior in persons 50-plus years of age living with HIV/AIDS.

Authors:  Travis I Lovejoy; Timothy G Heckman; Kathleen J Sikkema; Nathan B Hansen; Arlene Kochman; Julie A Suhr; John P Garske; Christopher J Johnson
Journal:  AIDS Behav       Date:  2008-04-04

10.  Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Authors:  Anika Guha; Matthew R Brier; Mario Ortega; Elizabeth Westerhaus; Brittany Nelson; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.